{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T17:15:54Z","timestamp":1783617354498,"version":"3.55.0"},"reference-count":107,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"27","license":[{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,7,3]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Numerous studies have investigated gout; however, a focused bibliometric evaluation of the most influential publications remains limited. This study identified and analyzed the top 100 most-cited articles on gout.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>The Web of Science Core Collection Science Citation Index Expanded database was searched using the term \u201cgout.\u201d Articles published from January 1, 2000 to April 30, 2026 were screened. The top 100 most-cited articles were selected, and data on citation rank, publication year, journal, impact factor, country, institution, author, study type, research topic, and keywords were extracted. Bibliometric analyses were performed to characterize publication patterns and research trends.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>The most-cited article was published in 2006 and received 4359 citations. The top 100 articles were published in 34 journals, with Annals of the Rheumatic Diseases contributing the largest proportion. The United States was the leading contributing country. The University of Pennsylvania was the most productive institution, and Choi HK was the most prolific author. Observational studies were the most common study design. Keyword co-occurrence analysis identified 4 major research domains: epidemiology, pathophysiological mechanisms, pain management, and comorbidities. Frequently occurring keywords included hyperuricemia, gout, management, risk, arthritis, uric acid, prevalence, coronary heart disease, quality of life, and febuxostat.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>This bibliometric analysis summarizes the most influential publications in gout research from 2000 to 2026. Major research priorities have shifted from serum urate, diagnosis, and pharmacological treatment toward risk assessment, long-term outcomes, disease burden, and comprehensive management. Hyperuricemia and urate-lowering therapy remain central themes, while emerging topics such as gut microbiota suggest increasing interest in multidisciplinary and precision approaches to gout care.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000049573","type":"journal-article","created":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T17:00:07Z","timestamp":1783098007000},"page":"e49573","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["The 100 top-cited articles in gout: A bibliometric analysis"],"prefix":"10.1097","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-7830-5371","authenticated-orcid":false,"given":"Zibing","family":"Zhao","sequence":"first","affiliation":[{"name":"College of Acupuncture and Tuina, Changchun University of Chinese Medicine, Changchun, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yayun","family":"Wang","sequence":"additional","affiliation":[{"name":"College of Chinese Medicine, Changchun University of Chinese Medicine, Changchun, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huixin","family":"Yan","sequence":"additional","affiliation":[{"name":"College of Acupuncture and Tuina, Changchun University of Chinese Medicine, Changchun, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinying","family":"Zhao","sequence":"additional","affiliation":[{"name":"College of Acupuncture and Tuina, Changchun University of Chinese Medicine, Changchun, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiapeng","family":"Chai","sequence":"additional","affiliation":[{"name":"College of Acupuncture and Tuina, Changchun University of Chinese Medicine, Changchun, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxun","family":"Zhang","sequence":"additional","affiliation":[{"name":"College of Acupuncture and Tuina, Changchun University of Chinese Medicine, Changchun, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuijuan","family":"Li","sequence":"additional","affiliation":[{"name":"College of Basic Medical Sciences, Shaanxi University of Chinese Medicine, Xianyang, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6402-3015","authenticated-orcid":false,"given":"Fuchun","family":"Wang","sequence":"additional","affiliation":[{"name":"College of Acupuncture and Tuina, Changchun University of Chinese Medicine, Changchun, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260709","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nature04516","article-title":"Gout-associated uric acid crystals activate the NALP3 inflammasome.","volume":"440","author":"Martinon","year":"2006","journal-title":"Nature"},{"key":"R2-20260709","doi-asserted-by":"crossref","first-page":"e40525","DOI":"10.1097\/MD.0000000000040525","article-title":"Research hotspots and trends related to pain in gouty arthritis from 2014 to 2024: a bibliometric analysis.","volume":"103","author":"Lu","year":"2024","journal-title":"Medicine (Baltimore)"},{"key":"R3-20260709","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1007\/s10067-023-06508-9","article-title":"Global status and trends in gout research from 2012 to 2021: a bibliometric and visual analysis.","volume":"42","author":"Wang","year":"2023","journal-title":"Clin Rheumatol"},{"key":"R4-20260709","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3389\/fpubh.2022.924676","article-title":"Mapping knowledge structure and global research trends in gout: a bibliometric analysis from 2001 to 2021.","volume":"10","author":"Wen","year":"2022","journal-title":"Front Public Health"},{"key":"R5-20260709","first-page":"12","article-title":"Global trends in research of gouty arthritis over past decade: a bibliometric analysis.","volume":"13","author":"Deng","year":"2022","journal-title":"Front Immunol"},{"key":"R6-20260709","first-page":"1582","article-title":"Increasing prevalence of gout and hyperuricemia over 10 years among older adults in a managed care population.","volume":"31","author":"Wallace","year":"2004","journal-title":"J Rheumatol"},{"key":"R7-20260709","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1136\/annrheumdis-2013-204647","article-title":"The global burden of gout: estimates from the global burden of disease 2010 study.","volume":"73","author":"Smith","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"R8-20260709","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1136\/ard.2004.024091","article-title":"Gout epidemiology: results from the UK general practice research database, 1990\u20131999.","volume":"64","author":"Mikuls","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"R9-20260709","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1002\/art.40807","article-title":"Contemporary prevalence of gout and hyperuricemia in the United States and decadal trends: the National Health and Nutrition Examination Survey, 2007\u20132016.","volume":"71","author":"Chen-Xu","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"R10-20260709","first-page":"2403","article-title":"Epidemiology of gout: is the incidence rising?","volume":"29","author":"Arromdee","year":"2002","journal-title":"J Rheumatol"},{"key":"R11-20260709","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1001\/archinternmed.2010.196","article-title":"A diagnostic rule for acute gouty arthritis in primary care without joint fluid analysis.","volume":"170","author":"Janssens","year":"2010","journal-title":"Arch Intern Med"},{"key":"R12-20260709","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1093\/rheumatology\/ker361","article-title":"National prevalence of gout derived from administrative health data in Aotearoa New Zealand.","volume":"51","author":"Winnard","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"R13-20260709","first-page":"1859","article-title":"Dietary and lifestyle changes associated with high prevalence of hyperuricemia and gout in the Shandong coastal cities of Eastern China.","volume":"35","author":"Miao","year":"2008","journal-title":"J Rheumatol"},{"key":"R14-20260709","first-page":"1640","article-title":"Hyperuricemia and gout in Taiwan: results from the Nutritional and Health Survey in Taiwan (1993\u201396).","volume":"28","author":"Chang","year":"2001","journal-title":"J Rheumatol"},{"key":"R15-20260709","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1136\/ard.2007.076232","article-title":"Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000\u20132005.","volume":"67","author":"Annemans","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"R16-20260709","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1136\/annrheumdis-2013-204463","article-title":"Rising burden of gout in the UK but continuing suboptimal management: a nationwide population study.","volume":"74","author":"Kuo","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"R17-20260709","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1136\/ard.2007.081604","article-title":"Gout is associated with more comorbidities, poorer health-related quality of life and higher healthcare utilisation in US veterans.","volume":"67","author":"Singh","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"R18-20260709","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1002\/art.22767","article-title":"Quality of care for gout in the US needs improvement.","volume":"57","author":"Singh","year":"2007","journal-title":"Arthritis Rheum"},{"key":"R19-20260709","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1136\/annrheumdis-2011-201254","article-title":"Epidemiology of gout and hyperuricaemia in Italy during the years 2005\u20132009: a nationwide population-based study.","volume":"72","author":"Trifir\u00f2","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"R20-20260709","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1136\/annrheumdis-2012-202421","article-title":"Tophaceous gout and high level of hyperuricaemia are both associated with increased risk of mortality in patients with gout.","volume":"73","author":"Perez-Ruiz","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"R21-20260709","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1093\/rheumatology\/kep364","article-title":"Gout: an independent risk factor for all-cause and cardiovascular mortality.","volume":"49","author":"Kuo","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"R22-20260709","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1161\/CIRCULATIONAHA.107.703389","article-title":"Independent impact of gout on mortality and risk for coronary heart disease.","volume":"116","author":"Choi","year":"2007","journal-title":"Circulation"},{"key":"R23-20260709","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1001\/archinte.168.10.1104","article-title":"Long-term cardiovascular mortality among middle-aged men with gout.","volume":"168","author":"Krishnan","year":"2008","journal-title":"Arch Intern Med"},{"key":"R24-20260709","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1002\/art.22014","article-title":"Gout and the risk of acute myocardial infarction.","volume":"54","author":"Krishnan","year":"2006","journal-title":"Arthritis Rheum"},{"key":"R25-20260709","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/1477-7525-10-117","article-title":"Tophi and frequent gout flares are associated with impairments to quality of life, productivity, and increased healthcare resource use: results from a cross-sectional survey.","volume":"10","author":"Khanna","year":"2012","journal-title":"Health Qual Life Outcomes"},{"key":"R26-20260709","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.3899\/jrheum.071229","article-title":"Quality of life and disability in patients with treatment-failure gout.","volume":"36","author":"Becker","year":"2009","journal-title":"J Rheumatol"},{"key":"R27-20260709","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1136\/annrheumdis-2013-205095","article-title":"Dual-energy CT for the diagnosis of gout: an accuracy and diagnostic yield study.","volume":"74","author":"Bongartz","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"R28-20260709","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1136\/annrheumdis-2011-200976","article-title":"Dual energy CT in gout: a prospective validation study.","volume":"71","author":"Choi","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"R29-20260709","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1148\/radiol.11102485","article-title":"Identification of intraarticular and periarticular uric acid crystals with dual-energy CT: initial evaluation.","volume":"261","author":"Glazebrook","year":"2011","journal-title":"Radiology"},{"key":"R30-20260709","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1136\/ard.2008.099713","article-title":"Dual energy computed tomography in tophaceous gout.","volume":"68","author":"Choi","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"R31-20260709","first-page":"8","article-title":"Intestinal microbiota distinguish gout patients from healthy humans.","volume":"6","author":"Guo","year":"2016","journal-title":"Sci Rep"},{"key":"R32-20260709","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1093\/rheumatology\/kem058","article-title":"Diagnosis of gout by ultrasound.","volume":"46","author":"Thiele","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"R33-20260709","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.joca.2008.06.003","article-title":"Hyaline cartilage involvement in patients with gout and calcium pyrophosphate deposition disease. An ultrasound study.","volume":"17","author":"Filippucci","year":"2009","journal-title":"Osteoarthritis Cartilage"},{"key":"R34-20260709","first-page":"1888","article-title":"Ultrasonographic measurement of tophi as an outcome measure for chronic gout.","volume":"34","author":"Perez-Ruiz","year":"2007","journal-title":"J Rheumatol"},{"key":"R35-20260709","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1136\/ard.2006.062802","article-title":"High-resolution ultrasonography of the first metatarsal phalangeal joint in gout: a controlled study.","volume":"66","author":"Wright","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"R36-20260709","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1136\/annrheumdis-2014-206397","article-title":"Urate crystal deposition in asymptomatic hyperuricaemia and symptomatic gout: a dual energy CT study.","volume":"74","author":"Dalbeth","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"R37-20260709","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1016\/S0140-6736(08)61343-4","article-title":"Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study.","volume":"372","author":"Dehghan","year":"2008","journal-title":"Lancet"},{"key":"R38-20260709","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1002\/art.10792","article-title":"Renal underexcretion of uric acid is present in patients with apparent high urinary uric acid output.","volume":"47","author":"Perez-Ruiz","year":"2002","journal-title":"Arthritis Rheum"},{"key":"R39-20260709","doi-asserted-by":"crossref","first-page":"10338","DOI":"10.1073\/pnas.0901249106","article-title":"Identification of a urate transporter, ABCG2, with a common functional polymorphism causing gout.","volume":"106","author":"Woodward","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"R40-20260709","doi-asserted-by":"crossref","first-page":"5ra11","DOI":"10.1126\/scitranslmed.3000237","article-title":"Common defects of ABCG2, a high-capacity urate exporter, cause gout: a function-based genetic analysis in a Japanese population.","volume":"1","author":"Matsuo","year":"2009","journal-title":"Sci Transl Med"},{"key":"R41-20260709","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1136\/ard.59.7.539","article-title":"Beneficial effects of weight loss associated with moderate calorie\/carbohydrate restriction, and increased proportional intake of protein and unsaturated fat on serum urate and lipoprotein levels in gout: a pilot study.","volume":"59","author":"Dessein","year":"2000","journal-title":"Ann Rheum Dis"},{"key":"R42-20260709","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/ncomms1756","article-title":"Decreased extra-renal urate excretion is a common cause of hyperuricemia.","volume":"3","author":"Ichida","year":"2012","journal-title":"Nat Commun"},{"key":"R43-20260709","first-page":"1045","article-title":"Community based epidemiological study on hyperuricemia and gout in Kin-Hu, Kinmen.","volume":"27","author":"Lin","year":"2000","journal-title":"J Rheumatol"},{"key":"R44-20260709","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1007\/s11926-013-0400-9","article-title":"The crystallization of monosodium urate.","volume":"16","author":"Martillo","year":"2014","journal-title":"Curr Rheumatol Rep"},{"key":"R45-20260709","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/art.33355","article-title":"NLRP3 inflammasome-mediatedneutrophil recruitment and hypernociception depend on leukotriene B4 in a murine model of gout.","volume":"64","author":"Amaral","year":"2012","journal-title":"Arthritis Rheum"},{"key":"R46-20260709","doi-asserted-by":"crossref","first-page":"e29318","DOI":"10.1371\/journal.pone.0029318","article-title":"Neutrophil extracellular trap formation is associated with IL-1\u03b2 and autophagy-related signaling in gout.","volume":"6","author":"Mitroulis","year":"2011","journal-title":"PLoS One"},{"key":"R47-20260709","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1016\/j.celrep.2017.02.004","article-title":"\u03b2-hydroxybutyrate deactivates neutrophil NLRP3 inflammasome to relieve gout flares.","volume":"18","author":"Goldberg","year":"2017","journal-title":"Cell Rep"},{"key":"R48-20260709","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.1002\/art.21238","article-title":"Innate immunity conferred by toll-like receptors 2 and 4 and myeloid differentiation factor 88 expression is pivotal to monosodium urate monohydrate crystal-induced inflammation.","volume":"52","author":"Liu-Bryan","year":"2005","journal-title":"Arthritis Rheum"},{"key":"R49-20260709","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1038\/s41588-019-0504-x","article-title":"Target genes, variants, tissues and transcriptional pathways influencing human serum urate levels.","volume":"51","author":"Tin","year":"2019","journal-title":"Nat Genet"},{"key":"R50-20260709","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41587-019-0321-x","article-title":"A laser-engraved wearable sensor for sensitive detection of uric acid and tyrosine in sweat.","volume":"38","author":"Yang","year":"2020","journal-title":"Nat Biotechnol"},{"key":"R51-20260709","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1002\/art.11079","article-title":"Role of S100A8 and S100A9 in neutrophil recruitment in response to monosodium urate monohydrate crystals in the air-pouch model of acute gouty arthritis.","volume":"48","author":"Ryckman","year":"2003","journal-title":"Arthritis Rheum"},{"key":"R52-20260709","doi-asserted-by":"crossref","first-page":"3237","DOI":"10.1002\/art.27667","article-title":"Engagement of fatty acids with toll-like receptor 2 drives interleukin-1\u03b2 production via the ASC\/caspase 1 pathway in monosodium urate monohydrate crystal-induced gouty arthritis.","volume":"62","author":"Joosten","year":"2010","journal-title":"Arthritis Rheum"},{"key":"R53-20260709","doi-asserted-by":"crossref","first-page":"E270","DOI":"10.1016\/S2665-9913(20)30065-5","article-title":"Dapansutrile, an oral selective NLRP3 inflammasome inhibitor, for treatment of gout flares: an open-label, dose-adaptive, proof-of-concept, phase 2a trial.","volume":"2","author":"Kl\u00fcck","year":"2020","journal-title":"Lancet Rheumatol"},{"key":"R54-20260709","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1172\/JCI28075","article-title":"MyD88-dependent IL-1 receptor signaling is essential for gouty inflammation stimulated by monosodium urate crystals.","volume":"116","author":"Chen","year":"2006","journal-title":"J Clin Invest"},{"key":"R55-20260709","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1161\/CIRCGENETICS.109.934455","article-title":"Multiple genetic loci influence serum urate levels and their relationship with gout and cardiovascular disease risk factors.","volume":"3","author":"Yang","year":"2010","journal-title":"Circ Cardiovasc Genet"},{"key":"R56-20260709","doi-asserted-by":"crossref","first-page":"R63","DOI":"10.1186\/ar2978","article-title":"The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial.","volume":"12","author":"Becker","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"R57-20260709","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/nm.3547","article-title":"Aggregated neutrophil extracellular traps limit inflammation by degrading cytokines and chemokines.","volume":"20","author":"Schauer","year":"2014","journal-title":"Nat Med"},{"key":"R58-20260709","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1002\/art.27356","article-title":"Cellular characterization of the gouty tophus: a quantitative analysis.","volume":"62","author":"Dalbeth","year":"2010","journal-title":"Arthritis Rheum"},{"key":"R59-20260709","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1136\/ard.2008.094201","article-title":"Mechanisms of bone erosion in gout: a quantitative analysis using plain radiography and computed tomography.","volume":"68","author":"Dalbeth","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"R60-20260709","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1001\/archinte.165.7.742","article-title":"Obesity, weight change, hypertension, diuretic use, and risk of gout in men - the health professionals follow-up study.","volume":"165","author":"Choi","year":"2005","journal-title":"Arch Intern Med"},{"key":"R61-20260709","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/S0140-6736(04)16000-5","article-title":"Alcohol intake and risk of incident gout in men: a prospective study.","volume":"363","author":"Choi","year":"2004","journal-title":"Lancet"},{"key":"R62-20260709","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1056\/NEJMoa035700","article-title":"Purine-rich foods, dairy and protein intake, and the risk of gout in men.","volume":"350","author":"Choi","year":"2004","journal-title":"N Engl J Med"},{"key":"R63-20260709","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1136\/bmj.39449.819271.BE","article-title":"Soft drinks, fructose consumption, and the risk of gout in men: prospective cohort study.","volume":"336","author":"Choi","year":"2008","journal-title":"BMJ"},{"key":"R64-20260709","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fmicb.2017.00268","article-title":"Combined signature of the fecal microbiome and metabolome in patients with gout.","volume":"8","author":"Shao","year":"2017","journal-title":"Front Microbiol"},{"key":"R65-20260709","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/s41522-021-00235-2","article-title":"Metagenomic analysis revealed the potential role of gut microbiome in gout.","volume":"7","author":"Chu","year":"2021","journal-title":"NPJ Biofilms Microbiomes"},{"key":"R66-20260709","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/art.20405","article-title":"A retrospective study of the relationship between serum urate level and recurrent attacks of gouty arthritis: evidence for reduction of recurrent gouty arthritis with antihyperuricemic therapy.","volume":"51","author":"Shoji","year":"2004","journal-title":"Arthritis Rheum"},{"key":"R67-20260709","first-page":"577","article-title":"Treatment of chronic gout. Can we determine when urate stores are depleted enough to prevent attacks of gout?","volume":"28","author":"Li-Yu","year":"2001","journal-title":"J Rheumatol"},{"key":"R68-20260709","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1136\/annrheumdis-2011-200801","article-title":"Patient and provider barriers to effective management of gout in general practice: a qualitative study.","volume":"71","author":"Spencer","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"R69-20260709","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/j.lfs.2004.10.031","article-title":"Selectivity of febuxostat, a novel non-purine inhibitor of xanthine oxidase\/xanthine dehydrogenase.","volume":"76","author":"Takano","year":"2005","journal-title":"Life Sci"},{"key":"R70-20260709","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1002\/art.20935","article-title":"Febuxostat, a novel nonpurine selective inhibitor of xanthine oxidase.","volume":"52","author":"Becker","year":"2005","journal-title":"Arthritis Rheum"},{"key":"R71-20260709","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1002\/art.24209","article-title":"Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: a 28-week, phase III, randomized, double-blind, parallel-group trial.","volume":"59","author":"Schumacher","year":"2008","journal-title":"Arthritis Rheum"},{"key":"R72-20260709","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0378-8741(00)00305-6","article-title":"Inhibition of xanthine oxidase by some Chinese medicinal plants used to treat gout.","volume":"73","author":"Kong","year":"2000","journal-title":"J Ethnopharmacol"},{"key":"R73-20260709","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1056\/NEJMoa050373","article-title":"Febuxostat compared with allopurinol in patients with hyperuricemia and gout.","volume":"353","author":"Becker","year":"2005","journal-title":"N Engl J Med"},{"key":"R74-20260709","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1093\/rheumatology\/ken457","article-title":"Febuxostat in the treatment of gout: 5-yr findings of the FOCUS efficacy and safety study.","volume":"48","author":"Schumacher","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"R75-20260709","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1136\/ard.2007.070755","article-title":"Concordance of the management of chronic gout in a UK primary-care population with the EULAR gout recommendations.","volume":"66","author":"Roddy","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"R76-20260709","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1002\/art.34488","article-title":"Starting dose is a risk factor for allopurinol hypersensitivity syndrome: a proposed safe starting dose of allopurinol.","volume":"64","author":"Stamp","year":"2012","journal-title":"Arthritis Rheum"},{"key":"R77-20260709","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/art.10511","article-title":"Effect of urate-lowering therapy on the velocity of size reduction of tophi in chronic gout.","volume":"47","author":"Perez-Ruiz","year":"2002","journal-title":"Arthritis Rheum"},{"key":"R78-20260709","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1056\/NEJMoa1710895","article-title":"Cardiovascular safety of febuxostat or allopurinol in patients with gout.","volume":"378","author":"White","year":"2018","journal-title":"N Engl J Med"},{"key":"R79-20260709","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1136\/ard.60.10.981","article-title":"Relation between adverse events associated with allopurinol and renal function in patients with gout.","volume":"60","author":"V\u00e1zquez-Mellado","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"R80-20260709","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/art.30119","article-title":"Using allopurinol above the dose based on creatinine clearance is effective and safe in patients with chronic gout, including those with renal impairment.","volume":"63","author":"Stamp","year":"2011","journal-title":"Arthritis Rheum"},{"key":"R81-20260709","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/01.rhu.0000209882.50228.9f","article-title":"Serum urate levels and gout flares \u2013 analysis from managed care data.","volume":"12","author":"Sarawate","year":"2006","journal-title":"J Clin Rheumatol"},{"key":"R82-20260709","first-page":"1646","article-title":"Dose adjustment of allopurinol according to creatinine clearance does not provide adequate control of hyperuricemia in patients with gout.","volume":"33","author":"Dalbeth","year":"2006","journal-title":"J Rheumatol"},{"key":"R83-20260709","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.3899\/jrheum.111533","article-title":"Colchicine use is associated with decreased prevalence of myocardial infarction in patients with gout.","volume":"39","author":"Crittenden","year":"2012","journal-title":"J Rheumatol"},{"key":"R84-20260709","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1002\/art.27327","article-title":"High versus low dosing of oral colchicine for early acute gout flare twenty-four-hour outcome of the first multicenter, randomized, double-blind, placebo-controlled, parallel-group, dose-comparison colchicine study.","volume":"62","author":"Terkeltaub","year":"2010","journal-title":"Arthritis Rheum"},{"key":"R85-20260709","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1002\/art.22403","article-title":"Pharmacokinetics and pharmacodynamics of intravenous PEGylated recombinant mammalian urate oxidase in patients with refractory gout.","volume":"56","author":"Sundy","year":"2007","journal-title":"Arthritis Rheum"},{"key":"R86-20260709","doi-asserted-by":"crossref","first-page":"R63","DOI":"10.1186\/ar4500","article-title":"Induced and pre-existing anti-polyethylene glycol antibody in a trial of every 3-week dosing of pegloticase for refractory gout, including in organ transplant recipients.","volume":"16","author":"Hershfield","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"R87-20260709","doi-asserted-by":"crossref","first-page":"R60","DOI":"10.1186\/ar4497","article-title":"Pegloticase immunogenicity: the relationship between efficacy and antibody development in patients treated for refractory chronic gout.","volume":"16","author":"Lipsky","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"R88-20260709","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1001\/jama.2011.1169","article-title":"Efficacy and tolerability of pegloticase for the treatment of chronic gout in patients refractory to conventional treatment two randomized controlled trials.","volume":"306","author":"Sundy","year":"2011","journal-title":"JAMA"},{"key":"R89-20260709","doi-asserted-by":"crossref","first-page":"R12","DOI":"10.1186\/ar1861","article-title":"Control of hyperuricemia in subjects with refractory gout, and induction of antibody against poly(ethylene glycol) (PEG), in a phase I trial of subcutaneous PEGylated urate oxidase.","volume":"8","author":"Ganson","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"R90-20260709","doi-asserted-by":"crossref","first-page":"C761","DOI":"10.1152\/ajpcell.00227.2008","article-title":"Probenecid, a gout remedy, inhibits pannexin 1 channels.","volume":"295","author":"Silverman","year":"2008","journal-title":"Am J Physiol Cell Physiol"},{"key":"R91-20260709","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/ng.2500","article-title":"Genome-wide association analyses identify 18 new loci associated with serum urate concentrations.","volume":"45","author":"K\u00f6ttgen","year":"2013","journal-title":"Nat Genet"},{"key":"R92-20260709","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/S0140-6736(18)32158-5","article-title":"Efficacy and cost-effectivenessof nurse-led care involving education and engagement of patients and a treat-to-target urate-lowering strategy versus usual care for gout: a randomised controlled trial.","volume":"392","author":"Doherty","year":"2018","journal-title":"Lancet"},{"key":"R93-20260709","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1136\/annrheumdis-2012-201676","article-title":"Patients with gout adhere to curative treatment if informed appropriately: proof-of-concept observational study.","volume":"72","author":"Rees","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"R94-20260709","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.amjmed.2011.09.033","article-title":"Comorbidities of gout and hyperuricemia in the US general population: NHANES 2007\u20132008.","volume":"125","author":"Zhu","year":"2012","journal-title":"Am J Med"},{"key":"R95-20260709","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1002\/art.39107","article-title":"A role for gut microbiota and the metabolite-sensing receptor GPR43 in a murine model of gout.","volume":"67","author":"Vieira","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"R96-20260709","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1136\/annrheumdis-2011-200908","article-title":"Canakinumab for acute gouty arthritis in patients with limited treatment options: results from two randomised, multicentre, active-controlled, double-blind trials and their initial extensions.","volume":"71","author":"Schlesinger","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"R97-20260709","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1053\/ajkd.2002.33911","article-title":"The association between gout and nephrolithiasis: the National Health and Nutrition Examination Survey III, 1988\u20131994.","volume":"40","author":"Kramer","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"R98-20260709","first-page":"368","article-title":"Anti-inflammatory activity of curcumin-loaded tetrahedral framework nucleic acids on acute gouty arthritis.","volume":"8","author":"Zhang","year":"2022","journal-title":"Bioact Mater"},{"key":"R99-20260709","first-page":"2429","article-title":"Colchicine for prophylaxis of acute flares when initiating allopurinol for chronic gouty arthritis.","volume":"31","author":"Borstad","year":"2004","journal-title":"J Rheumatol"},{"key":"R100-20260709","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1136\/annrheumdis-2014-206410","article-title":"Comorbidities in patients with gout prior to and following diagnosis: case-control study.","volume":"75","author":"Kuo","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"R101-20260709","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1136\/ard.2009.108936","article-title":"The interleukin 1 inhibitor rilonacept in treatment of chronic gouty arthritis: results of a placebo-controlled, monosequence crossover, non-randomised, single-blind pilot study.","volume":"68","author":"Terkeltaub","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"R102-20260709","doi-asserted-by":"crossref","first-page":"R28","DOI":"10.1186\/ar2143","article-title":"A pilot study of IL-1 inhibition by anakinra in acute gout.","volume":"9","author":"So","year":"2007","journal-title":"Arthritis Res Ther"},{"key":"R103-20260709","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1016\/S0140-6736(08)60799-0","article-title":"Use of oral prednisolone or naproxen for the treatment of gout arthritis: a double-blind, randomised equivalence trial.","volume":"371","author":"Janssens","year":"2008","journal-title":"Lancet"},{"key":"R104-20260709","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1136\/ard.2010.144063","article-title":"Canakinumab reduces the risk of acute gouty arthritis flares during initiation of allopurinol treatment: results of a double-blind, randomised study.","volume":"70","author":"Schlesinger","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"R105-20260709","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/art.22466","article-title":"Prevalence of the metabolic syndrome in patients with gout: the Third National Health and Nutrition Examination Survey.","volume":"57","author":"Choi","year":"2007","journal-title":"Arthritis Rheum"},{"key":"R106-20260709","doi-asserted-by":"crossref","first-page":"d8190","DOI":"10.1136\/bmj.d8190","article-title":"Antihypertensive drugs and risk of incident gout among patients with hypertension: population based case-control study.","volume":"344","author":"Choi","year":"2012","journal-title":"BMJ"},{"key":"R107-20260709","doi-asserted-by":"crossref","first-page":"j1794","DOI":"10.1136\/bmj.j1794","article-title":"The dietary approaches to stop hypertension (DASH) diet, western diet, and risk of gout in men: prospective cohort study.","volume":"357","author":"Rai","year":"2017","journal-title":"BMJ"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000049573","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T17:01:05Z","timestamp":1783616465000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000049573"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,3]]},"references-count":107,"journal-issue":{"issue":"27","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000049573","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,3]]},"assertion":[{"value":"2025-03-24","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-17","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}